C-type natriuretic peptide suppresses mesangial proliferation and matrix expression via a MMPs/TIMPs-independent pathway in vitro

References

• Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1987;1:272–81.
   PubMed Web of Science ®Google Scholar
• Singh LP, Jiang Y, Cheng DW. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells. Int J Biol Sci 2006;3:27–39.
   PubMed Web of Science ®Google Scholar
• Scindia YM, Deshmukh US, Bagavant H. Mesangial pathology in glomerular disease: targets for therapeutic intervention. Adv Drug Deliv Rev 2010;62:1337–43.
   PubMed Web of Science ®Google Scholar
• Sudoh T, Minamino N, Kangawa K, et al. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990;168:863–70.
   PubMed Web of Science ®Google Scholar
• Klinger JR, Warburton R, Carino GP, et al. Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells. Exp Cell Res 2006;312:401–10.
   PubMed Web of Science ®Google Scholar
• Woodard GE, Li X, Rosado JA. Characteristics of the renal C-type natriuretic peptide receptor in hypertrophied and developing rat kidney. J Mol Endocrinol 2005;35:519–30.
   PubMed Web of Science ®Google Scholar
• Hu P, Zhao XQ, Wang J, et al. Paradoxical expressions of natriuretic peptide receptor-C and neutral endopeptidase account for C-type natriuretic peptide decline during the progression of experimental obstructive nephropathy. J Renin Angiotensin Aldosterone Syst 2014;15:458–65.
   PubMed Web of Science ®Google Scholar
• Hu P, Zhang XC, Kong HB, et al. Exogenous C-type natriuretic peptide infusion ameliorates unilateral ureteral obstruction-induced tubulointerstitial fibrosis in rats. Lab Invest 2015;95:263–72.
   PubMed Web of Science ®Google Scholar
• Canaan-Kühl S, Ostendorf T, Zander K, et al. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int 1998;53:1143–51.
   PubMed Web of Science ®Google Scholar
• Rodgers K, McMahon B, Mitchell D, et al. Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am J Pathol 2005;167:683–94.
   PubMed Web of Science ®Google Scholar
• Zheng N, Wang D, Ming H, et al. BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R. BMC Nephrol 2015;16:72.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101–8.
   PubMed Web of Science ®Google Scholar
• Cammarata PR, Braun B, Dimitrijevich SD, et al. Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells. Mol Vis 2010;16:630–8.
   PubMed Web of Science ®Google Scholar
• Doi K, Ikeda T, Itoh H, et al. C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vasc Biol 2001;21:930–6.
   PubMed Web of Science ®Google Scholar
• Furuya M, Aisaka K, Miyazaki T, et al. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun 1993;193:248–53.
   PubMed Web of Science ®Google Scholar
• Zhao J, Ardaillou N, Lu CY, et al. Characterization of C-type natriuretic peptide receptors in human mesangial cells. Kidney Int 1994;46:717–25.
   PubMed Web of Science ®Google Scholar
• Segawa K, Minami K, Jimi N, et al. C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism. Naunyn Schmiedebergs Arch Pharmacol 1998;357:70–6.
   PubMed Web of Science ®Google Scholar
• Hutchinson HG, Trindade PT, Cunanan DB, et al. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 1997;35:158–67.
   PubMed Web of Science ®Google Scholar
• Khambata RS, Panayiotou CM, Hobbs AJ. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide. Br J Pharmacol 2011;164:584–97.
   PubMed Web of Science ®Google Scholar
• Seret G, Le Meur Y, Renaudineau Y, et al. Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis. Clin Dev Immunol 2012;2012:579670.
   PubMedGoogle Scholar
• Zhang Y, Yang J, Jiang S, et al. The lupus-derived anti-double-stranded DNA IgG contributes to myofibroblast-like phenotype in mesangial cells. J Clin Immunol 2012;32:1270–8.
   PubMed Web of Science ®Google Scholar
• Hu P, Qin YH, Pei J, et al. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: a comparative study between ATRA and benazepril. Exp Mol Pathol 2010;89:51–7.
   PubMed Web of Science ®Google Scholar
• Osawa H, Yamabe H, Kaizuka M, et al. C-Type natriuretic peptide inhibits proliferation and monocyte chemoattractant protein-1 secretion in cultured human mesangial cells. Nephron 2000;86:467–72.
   PubMed Web of Science ®Google Scholar
• Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol 2015;44–46:247–54.
   PubMed Web of Science ®Google Scholar
• Qin YH, Lei FY, Hu P, et al. Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr Nephrol 2009;24:1477–86.
   PubMed Web of Science ®Google Scholar
• Qin YH, Zhou TB, Lei FY, et al. Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children? Nephrology (Carlton) 2011;16:93–9.
   PubMed Web of Science ®Google Scholar
• Surendran K, Simon TC. CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury. Am J Physiol Renal Physiol 2003;284:F653–62.
   PubMed Web of Science ®Google Scholar
• Walther T, Schuitheiss HP, Tschöpe C. Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus. Cardiovasc Res 2001;51:562–6.
   PubMed Web of Science ®Google Scholar
• Suga S, Nakao K, Itoh H, et al. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of “vascular natriuretic peptide system”. J Clin Invest 1992;90:1145–9.
   PubMed Web of Science ®Google Scholar
• Hu P, Huang BY, Xia X, et al. Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway. J Recept Signal Transduct Res 2016;36:213–19.
   PubMed Web of Science ®Google Scholar
• Krejci P, Masri B, Fontaine V, et al. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci 2005;118:5089–100.
   PubMed Web of Science ®Google Scholar